These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22749034)

  • 1. Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome.
    Dambruoso I; Boni M; Rossi M; Zappasodi P; Calvello C; Zappatore R; Cavigliano PM; Giardini I; Rocca B; Caresana M; Astori C; Cazzola M; Castagnola C; Bernasconi P
    Cancer Genet; 2012 Jun; 205(6):285-94. PubMed ID: 22749034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities.
    de Oliveira FM; Miguel CE; Lucena-Araujo AR; de Lima AS; Falcão RP; Rego EM
    Med Oncol; 2013 Mar; 30(1):483. PubMed ID: 23389918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
    Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
    Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
    Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
    PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation in TET2 in myeloid cancers.
    Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
    N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 cases.
    Klaus M; Psaraki A; Mastrodemou S; Pyrovolaki K; Mavroudi I; Kalpadakis C; Papadaki HA
    Leuk Res; 2011 Mar; 35(3):413-5. PubMed ID: 21087791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
    Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
    Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions.
    La Starza R; Crescenzi B; Nofrini V; Barba G; Matteucci C; Brandimarte L; Pierini V; Testoni N; Musto P; Paolini S; Gianfelici V; Storlazzi CT; Pierini A; Berchicci L; Gorello P; Mecucci C
    Leuk Res; 2012 Jan; 36(1):37-41. PubMed ID: 21920603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
    Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
    Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.
    Mohamedali AM; Smith AE; Gaken J; Lea NC; Mian SA; Westwood NB; Strupp C; Gattermann N; Germing U; Mufti GJ
    J Clin Oncol; 2009 Aug; 27(24):4002-6. PubMed ID: 19528370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
    Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
    Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1.
    Thorsen J; Aamot HV; Roberto R; Tjønnfjord GE; Micci F; Heim S
    Cancer Genet; 2012 Oct; 205(10):528-32. PubMed ID: 22944560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
    Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.
    Smith AE; Mohamedali AM; Kulasekararaj A; Lim Z; Gäken J; Lea NC; Przychodzen B; Mian SA; Nasser EE; Shooter C; Westwood NB; Strupp C; Gattermann N; Maciejewski JP; Germing U; Mufti GJ
    Blood; 2010 Nov; 116(19):3923-32. PubMed ID: 20693430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.
    Yamamoto K; Nagata K; Yagasaki F; Tsurukubo Y; Tamura A; Taniwaki M; Hamaguchi H
    Cancer Genet Cytogenet; 2000 Jun; 119(2):113-7. PubMed ID: 10867145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
    Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation.
    Wlodarska I; Selleri L; La Starza R; Paternotte C; Evans GA; Boogaerts M; Van den Berghe H; Mecucci C
    Genes Chromosomes Cancer; 1999 Mar; 24(3):199-206. PubMed ID: 10451699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.